Neuronetics Inc (STIM) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Neuronetics Inc   (NASDAQ: STIM)
 

Neuronetics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Neuronetics Inc 's inventory turnover ratio sequentially decreased to 16.61 in the second quarter 2026, otherwise the ratio remained above the average, as STIM's markets remain strong.Neuronetics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 22 days, from 21 days, in the Mar 31 2026 quarter.

Within Healthcare sector 18 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 217 in the first quarter 2026, to 249.

STIM Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Neuronetics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

STIM Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 11.31 % 15.88 % 1.86 % -12.86 % -19.52 %
Y / Y Cost of Sales Growth 1.72 % 12.5 % 150 % 400 % 400 %
Inventory Turnover Ratio (TTM) 16.61 17.04 17.21 14.56 10.54
STIM's Total Ranking # 249 # 217 # 201 # 236 # 236
Average inventory processing period 22 21 21 25 35
Seq. Inventory Growth 16.69 % 8.97 % 0.12 % -12.56 % 21.48 %
Seq. Cost of Sales Growth 13.03 % -10 % 0 % 0 % 25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 7
Healthcare Sector # 19
Overall Market # 249

Inventory Turnover Ratio Statistics
High Average Low
17.21 5.18 0.6
(Dec 31 2025)   (Jun 30 2018)



STIM Company Profile >> Back to STIM Efficiency Comparisons >> Compare STIM Inventory Turnover Ratio to its Competitors

Financial Statements
Neuronetics Inc 's Inventories $ 6 Millions Visit STIM's Balance sheet
Neuronetics Inc 's Cost of Revenues TTM $ 78 Millions Visit STIM's Income Statement
What are STIM's Sales? Visit STIM's Sales by Segment

Other Inventory Turnover Ratios
Neuronetics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
STIM's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for STIM's Competitors
Inventory Turnover Ratio for STIM's Suppliers
Inventory Turnover Ratio for STIM's Customers

You may also want to know
STIM's Sales Growth Rates STIM's Pe Price to earnings ratio STIM's Receivables Turnover Ratio STIM's Stock Quote
STIM's Net Income Growth Rates STIM's Ps Price to Sales ratio STIM's Sales per Employee STIM's Asset Turnover Ratio
STIM's Net Margin STIM's Pb Price to Book ratio STIM's Financial Strength Ratios STIM's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Quest Diagnostics Inc  37.13 $ 7,732.000  Millions$ 208  Millions
Vaso Corporation  33.32 $ 28.238  Millions$ 1  Millions
Prophase Labs Inc   26.86 $ 3.196  Millions$ 0  Millions
Omada Health Inc   24.96 $ 97.232  Millions$ 4  Millions
Viemed Healthcare Inc   24.71 $ 128.283  Millions$ 5  Millions
Teladoc Health Inc   22.32 $ 772.590  Millions$ 35  Millions
Lucid Diagnostics Inc   21.74 $ 9.740  Millions$ 0  Millions
Adapthealth Corp   20.25 $ 2,676.899  Millions$ 132  Millions
Sbc Medical Group Holdings Incorporated  19.68 $ 48.095  Millions$ 2  Millions
Labcorp Holdings Inc   19.29 $ 10,203.900  Millions$ 529  Millions
Aspira Women s Health inc   19.13 $ 5.073  Millions$ 0  Millions
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.